Tech Company M&A Transactions
Meritage Pharma Acquisition
Meritage Pharma was bought by Shire Pharmaceuticals. The transaction occurred on 2/24/2015. Shire Pharmaceuticals said the transaction price was $245 million.
Transaction Overview
Company Name
Acquired By
Announced On
2/24/2015
Transaction Type
M&A
Amount
$245,000,000
M&A Terms
Shire has acquired Meritage, a privately-held company, for an upfront fee of $70 million and additional contingent payments based on the achievement of development and regulatory milestones.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12555 High Bluff Drive 385
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Meritage Pharma is committed to the development of prescription products based on proven safe and effective molecules to meet the unmet needs of patients and their caregivers. Meritage Pharma's initial product candidate is intended for the treatment of allergic inflammation of the gastrointestinal tract.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Elaine Phillips
Chief Scientific Officer
Malcolm Hill
Browse more venture capital transactions:
Prev: 2/24/2015: NGM Biopharmaceuticals venture capital transaction
Next: 2/24/2015: Veritone venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs